Sanjivani Paranteral's Q4 FY 2025-26 Quarterly Results

Result Summary

• Sanjivani Paranteral Ltd reported a 38.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 25.8%.
• Its expenses for the quarter were down by 32.4% QoQ and 20.9% YoY.
• The net profit decreased 80.6% QoQ and decreased 75.3% YoY.
• The earnings per share (EPS) of Sanjivani Paranteral Ltd stood at 0.49 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Sanjivani Paranteral Ltd is a company operating in the pharmaceutical industry, primarily focused on the production and distribution of parenteral drugs and related healthcare products. The company is recognized for its contributions to the healthcare sector, providing a range of products that cater to critical care and other therapeutic needs. However, specific details about any recent major developments, strategic initiatives, or changes within the company are not available in the provided data. The provided information is limited to financial performance, with no additional context about operational activities or market position.

Revenue

In the fourth quarter of fiscal year 2026, Sanjivani Paranteral Ltd reported a total income of ₹13.81 crores. This represents a significant decrease of 38.2% compared to the previous quarter (Q3FY26), where the total income was ₹22.36 crores. When compared to the same quarter in the previous year (Q4FY25), the total income declined by 25.8% from ₹18.61 crores. These figures indicate a notable reduction in revenue on both a quarterly and annual basis.

Profitability

For Q4FY26, the company reported a profit before tax (PBT) of ₹1.20 crores, which is a sharp decline of 67.6% from the ₹3.70 crores recorded in Q3FY26. On a year-over-year basis, PBT decreased by 54.7% from the ₹2.65 crores reported in Q4FY25. The tax expense for Q4FY26 was ₹0.65 crores, down 29.3% from the previous quarter but up 38.3% from the same quarter last year. The profit after tax (PAT) for Q4FY26 was ₹0.54 crores, marking an 80.6% decrease from Q3FY26 and a 75.3% decrease from Q4FY25. The earnings per share (EPS) for the quarter was ₹0.49, showing a reduction of 77.8% QoQ and 69.6% YoY.

Operating Metrics

The operating metrics of Sanjivani Paranteral Ltd, as reflected in the financial data, highlight a decrease in total expenses for Q4FY26, which amounted to ₹12.61 crores. This is a reduction of 32.4% from Q3FY26, where total expenses were ₹18.66 crores, and a decrease of 20.9% compared to Q4FY25, which reported ₹15.95 crores. The significant reduction in expenses aligns with the overall downward trend in income and profitability. However, details on specific operational activities or efficiencies contributing to these changes are not available in the data. Key financial ratios such as the P/E ratio, debt-to-equity ratio, and current ratio have not been provided in the current dataset, limiting further analysis on operational performance.